F. Cömert Önder Et Al. , "Novel Etodolac Derivatives as Eukaryotic Elongation Factor 2 Kinase (eEF2K) Inhibitors for Targeted Cancer Therapy," RSC MEDICINAL CHEMISTRY , no.x, 2022
Cömert Önder, F. Et Al. 2022. Novel Etodolac Derivatives as Eukaryotic Elongation Factor 2 Kinase (eEF2K) Inhibitors for Targeted Cancer Therapy. RSC MEDICINAL CHEMISTRY , no.x .
Cömert Önder, F., Siyah, P., Durdağı, S., Ay, M., & Özpolat, B., (2022). Novel Etodolac Derivatives as Eukaryotic Elongation Factor 2 Kinase (eEF2K) Inhibitors for Targeted Cancer Therapy. RSC MEDICINAL CHEMISTRY , no.x.
Cömert Önder, FERAH Et Al. "Novel Etodolac Derivatives as Eukaryotic Elongation Factor 2 Kinase (eEF2K) Inhibitors for Targeted Cancer Therapy," RSC MEDICINAL CHEMISTRY , no.x, 2022
Cömert Önder, FERAH C. Et Al. "Novel Etodolac Derivatives as Eukaryotic Elongation Factor 2 Kinase (eEF2K) Inhibitors for Targeted Cancer Therapy." RSC MEDICINAL CHEMISTRY , no.x, 2022
Cömert Önder, F. Et Al. (2022) . "Novel Etodolac Derivatives as Eukaryotic Elongation Factor 2 Kinase (eEF2K) Inhibitors for Targeted Cancer Therapy." RSC MEDICINAL CHEMISTRY , no.x.
@article{article, author={FERAH CÖMERT ÖNDER Et Al. }, title={Novel Etodolac Derivatives as Eukaryotic Elongation Factor 2 Kinase (eEF2K) Inhibitors for Targeted Cancer Therapy}, journal={RSC MEDICINAL CHEMISTRY}, year=2022}